Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEMAPHORE: Tocilizumab vs placebo in glucocorticoid-dependent polymyalgia rheumatica
2015-005389-51Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Jun 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in polymyalgia rheumatica (PMR) comparing Tocilizumab arm with Placebo arm (2 arms). Started Jun 2016; status: completed.
02
Drugs
tocilizumab
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on 2015-005389-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005389-51.